Hyperprolactinemia is usually a side impact of dopamine antagonists as blockade of D2 receptors inside the tuberoinfundibular pathway leads to increased plasma levels of prolactin because of improved secretion by lactotrophs inside the anterior pituitary. I released One more limited story assortm